loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Niva Bupa Health Insurance Company Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Niva Bupa Health Insurance Company Ltd. 30 Jul 2026 16:07 PM

Q1FY27 Quarterly Result Announced for Niva Bupa Health Insurance Company Ltd.

General Insurance company Niva Bupa Health Insurance Company announced Q1FY27 results

Financial Highlights:

  • Insurance Revenue for Q1FY27 stood at Rs 2,27,372 lakh, representing a YoY increase of 28.56% from Rs 1,76,861 lakh in Q1FY26 and a QoQ growth of 7.44% from Rs 2,11,618 lakh in Q4FY26.
  • Total Investment Income for the quarter Q1FY27 was Rs 19,754 lakh, marking a 21.09% YoY growth compared to Rs 16,314 lakh in Q1FY26 and an increase of 46.46% QoQ from Rs 13,488 lakh in Q4FY26.
  • Profit before tax for Q1FY27 was Rs 18,374 lakh, showing a significant YoY growth of 87.64% from Rs 9,792 lakh in Q1FY26 and a marginal QoQ increase of 1.66% from Rs 18,074 lakh in Q4FY26.
  • Net profit for Q1FY27 reached Rs 13,780 lakh, registering a 92.89% YoY increase from Rs 7,144 lakh in Q1FY26, while recording a QoQ decline of 13.53% from Rs 15,936 lakh in Q4FY26.
  • Total Comprehensive Income for Q1FY27 was Rs 22,919 lakh, as against Rs 13,124 lakh in Q1FY26 and Rs 4,034 lakh in Q4FY26.
  • Basic and Diluted earnings per share (EPS) for Q1FY27 was Rs 0.75 and Rs 0.74 respectively, compared to Rs 0.39 and Rs 0.39 in Q1FY26.
  • Gross Written Premium (GWP) for Q1FY27 stood at Rs 2,14,996 lakh, up 31.75% YoY from Rs 1,63,190 lakh in Q1FY26.
  • The company reported a Net Worth of Rs 3,83,578 lakh as of June 30, 2026.

Business Highlights:

  • Fundraising: The Board of Directors approved the issuance of listed, rated, unsecured, subordinated, redeemable, non-convertible debentures of up to Rs 500.00 crore on a private placement basis.
  • Regulatory Update: The company has filed an application with IRDAI for forbearance regarding Expenses of Management (EOM) exceeding allowable limits for FY25.
  • Solvency and Margins: The Solvency Ratio for Q1FY27 was 2.25, compared to 2.86 in Q1FY26. The Net Insurance Margin improved to 4.44% in Q1FY27 from 0.43% in Q1FY26.
  • Claims and Operations: The Claims Ratio for General Insurance and Claims Experience Ratio for Life Insurance business stood at 63.01% in Q1FY27 compared to 66.83% in Q1FY26.
  • Segment Performance:
    • Health Segment: Reported a total income of Rs 2,47,175 lakh and a segment profit of Rs 12,883 lakh.
    • Personal Accident Segment: Reported a total income of Rs 3,583 lakh and a segment profit of Rs 926 lakh.
    • Travel Segment: Reported a total income of Rs 317 lakh and a segment loss of Rs 29 lakh.

Result PDF

General Insurance company Niva Bupa Health Insurance Company announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • In Q4FY25, Niva Bupa achieved a Gross Written Premium (GWP) of Rs 2,395 crore, reflecting a strong YoY growth of 36%.
  • When adjusted for the 1/N accounting impact, the GWP for Q4FY25 stood at Rs 2,079 crore, representing an 18% YoY growth.

FY25 Financial Highlights:

  • For the full financial year FY25, the company recorded a GWP of Rs 7,407 crore, marking a 32% YoY growth.
  • The company’s PAT grew to Rs 214 crore in FY25 against 82 crore in FY24, demonstrating 161% YoY growth.
  • For FY25, the adjusted GWP was Rs 6,762 crore, reflecting a growth of 21% compared to FY24.
  • The Solvency Ratio strengthened to 3.03 in FY25 from 2.55 in FY24, demonstrating sound financial stability and ability to meet long-term obligations.
  • Delivering on its commitment to a seamless claims experience, Niva Bupa improved its Claims Settlement Ratio from 91.9% in FY24 to 92.4% in FY25, underlining its focus on prompt and hassle-free service for policyholders.
  • Simultaneously, Niva Bupa achieved a significant reduction in its Expense of Management, which dropped from 39.3% in FY24 to 37.4% in FY25, driven by its ongoing automation and digitization initiatives across the value chain.

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app